"Global Bacteriophage Therapy Market Overview:
Global Bacteriophage Therapy Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Bacteriophage Therapy Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Bacteriophage Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Bacteriophage Therapy Market:
The Bacteriophage Therapy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Bacteriophage Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Bacteriophage Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Bacteriophage Therapy market has been segmented into:
Escherichia coli
Staphylococcus aureus
Streptococcus
Pseudomonas aeruginosa
Salmonella
and Others
By Application, Bacteriophage Therapy market has been segmented into:
Urinary Tract Infections
Chronic Otitis
Dental Extraction
Chronic Ulcerative Colitis
Bone Infection
Wound and Skin Infections
Cystic Fibrosis
and Other
By Route of Administration (Oral
Topical
and Parenteral
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Bacteriophage Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Bacteriophage Therapy market.
Top Key Players Covered in Bacteriophage Therapy market are:
Armata Pharmaceuticalsinc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytixinc.
Phageluxinc.
Nextbiotics
InnoPhage
Ltd
Locus Biosciencesinc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhageProinc.
Adaptive Phage Therapeutics
Enbiotixinc.
Intodeworldinc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
OPTIPHARM Co. Ltd
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Bacteriophage Therapy Market by Type
4.1 Bacteriophage Therapy Market Snapshot and Growth Engine
4.2 Bacteriophage Therapy Market Overview
4.3 Escherichia coli
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Escherichia coli: Geographic Segmentation Analysis
4.4 Staphylococcus aureus
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Staphylococcus aureus: Geographic Segmentation Analysis
4.5 Streptococcus
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Streptococcus: Geographic Segmentation Analysis
4.6 Pseudomonas aeruginosa
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Pseudomonas aeruginosa: Geographic Segmentation Analysis
4.7 Salmonella
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Salmonella: Geographic Segmentation Analysis
4.8 and Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 and Others: Geographic Segmentation Analysis
Chapter 5: Bacteriophage Therapy Market by Application
5.1 Bacteriophage Therapy Market Snapshot and Growth Engine
5.2 Bacteriophage Therapy Market Overview
5.3 Urinary Tract Infections
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Urinary Tract Infections: Geographic Segmentation Analysis
5.4 Chronic Otitis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Chronic Otitis: Geographic Segmentation Analysis
5.5 Dental Extraction
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Dental Extraction: Geographic Segmentation Analysis
5.6 Chronic Ulcerative Colitis
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Chronic Ulcerative Colitis: Geographic Segmentation Analysis
5.7 Bone Infection
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Bone Infection: Geographic Segmentation Analysis
5.8 Wound and Skin Infections
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Wound and Skin Infections: Geographic Segmentation Analysis
5.9 Cystic Fibrosis
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Cystic Fibrosis: Geographic Segmentation Analysis
5.10 and Other
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 and Other: Geographic Segmentation Analysis
5.11 By Route of Administration (Oral
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 By Route of Administration (Oral: Geographic Segmentation Analysis
5.12 Topical
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Topical: Geographic Segmentation Analysis
5.13 and Parenteral
5.13.1 Introduction and Market Overview
5.13.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.13.3 Key Market Trends, Growth Factors and Opportunities
5.13.4 and Parenteral: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Bacteriophage Therapy Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ARMATA PHARMACEUTICALSINC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ELIAVA BIOPREPARATIONS LTD.
6.4 PHERECYDES PHARMA
6.5 INTRALYTIXINC.
6.6 PHAGELUXINC.
6.7 NEXTBIOTICS
6.8 INNOPHAGE
6.9 LTD
6.10 LOCUS BIOSCIENCESINC.
6.11 TECHNOPHAGE
6.12 ELIGO BIOSCIENCE SA
6.13 PHAGOMED BIOPHARMA GMBH.
6.14 PHAGEPROINC.
6.15 ADAPTIVE PHAGE THERAPEUTICS
6.16 ENBIOTIXINC.
6.17 INTODEWORLDINC.
6.18 BIOMX LTD.
6.19 PHI THERAPEUTICS
6.20 FIXED-PHAGE LTD.
6.21 MICREOS BV
6.22 CONTRAFECT CORPORATION
6.23 OPTIPHARM CO.
6.24 LTD.
Chapter 7: Global Bacteriophage Therapy Market By Region
7.1 Overview
7.2. North America Bacteriophage Therapy Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Escherichia coli
7.2.4.2 Staphylococcus aureus
7.2.4.3 Streptococcus
7.2.4.4 Pseudomonas aeruginosa
7.2.4.5 Salmonella
7.2.4.6 and Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Urinary Tract Infections
7.2.5.2 Chronic Otitis
7.2.5.3 Dental Extraction
7.2.5.4 Chronic Ulcerative Colitis
7.2.5.5 Bone Infection
7.2.5.6 Wound and Skin Infections
7.2.5.7 Cystic Fibrosis
7.2.5.8 and Other
7.2.5.9 By Route of Administration (Oral
7.2.5.10 Topical
7.2.5.11 and Parenteral
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Bacteriophage Therapy Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Escherichia coli
7.3.4.2 Staphylococcus aureus
7.3.4.3 Streptococcus
7.3.4.4 Pseudomonas aeruginosa
7.3.4.5 Salmonella
7.3.4.6 and Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Urinary Tract Infections
7.3.5.2 Chronic Otitis
7.3.5.3 Dental Extraction
7.3.5.4 Chronic Ulcerative Colitis
7.3.5.5 Bone Infection
7.3.5.6 Wound and Skin Infections
7.3.5.7 Cystic Fibrosis
7.3.5.8 and Other
7.3.5.9 By Route of Administration (Oral
7.3.5.10 Topical
7.3.5.11 and Parenteral
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Bacteriophage Therapy Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Escherichia coli
7.4.4.2 Staphylococcus aureus
7.4.4.3 Streptococcus
7.4.4.4 Pseudomonas aeruginosa
7.4.4.5 Salmonella
7.4.4.6 and Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Urinary Tract Infections
7.4.5.2 Chronic Otitis
7.4.5.3 Dental Extraction
7.4.5.4 Chronic Ulcerative Colitis
7.4.5.5 Bone Infection
7.4.5.6 Wound and Skin Infections
7.4.5.7 Cystic Fibrosis
7.4.5.8 and Other
7.4.5.9 By Route of Administration (Oral
7.4.5.10 Topical
7.4.5.11 and Parenteral
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Bacteriophage Therapy Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Escherichia coli
7.5.4.2 Staphylococcus aureus
7.5.4.3 Streptococcus
7.5.4.4 Pseudomonas aeruginosa
7.5.4.5 Salmonella
7.5.4.6 and Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Urinary Tract Infections
7.5.5.2 Chronic Otitis
7.5.5.3 Dental Extraction
7.5.5.4 Chronic Ulcerative Colitis
7.5.5.5 Bone Infection
7.5.5.6 Wound and Skin Infections
7.5.5.7 Cystic Fibrosis
7.5.5.8 and Other
7.5.5.9 By Route of Administration (Oral
7.5.5.10 Topical
7.5.5.11 and Parenteral
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Bacteriophage Therapy Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Escherichia coli
7.6.4.2 Staphylococcus aureus
7.6.4.3 Streptococcus
7.6.4.4 Pseudomonas aeruginosa
7.6.4.5 Salmonella
7.6.4.6 and Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Urinary Tract Infections
7.6.5.2 Chronic Otitis
7.6.5.3 Dental Extraction
7.6.5.4 Chronic Ulcerative Colitis
7.6.5.5 Bone Infection
7.6.5.6 Wound and Skin Infections
7.6.5.7 Cystic Fibrosis
7.6.5.8 and Other
7.6.5.9 By Route of Administration (Oral
7.6.5.10 Topical
7.6.5.11 and Parenteral
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Bacteriophage Therapy Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Escherichia coli
7.7.4.2 Staphylococcus aureus
7.7.4.3 Streptococcus
7.7.4.4 Pseudomonas aeruginosa
7.7.4.5 Salmonella
7.7.4.6 and Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Urinary Tract Infections
7.7.5.2 Chronic Otitis
7.7.5.3 Dental Extraction
7.7.5.4 Chronic Ulcerative Colitis
7.7.5.5 Bone Infection
7.7.5.6 Wound and Skin Infections
7.7.5.7 Cystic Fibrosis
7.7.5.8 and Other
7.7.5.9 By Route of Administration (Oral
7.7.5.10 Topical
7.7.5.11 and Parenteral
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Bacteriophage Therapy Scope:
|
Report Data
|
Bacteriophage Therapy Market
|
|
Bacteriophage Therapy Market Size in 2025
|
USD XX million
|
|
Bacteriophage Therapy CAGR 2025 - 2032
|
XX%
|
|
Bacteriophage Therapy Base Year
|
2024
|
|
Bacteriophage Therapy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Armata Pharmaceuticalsinc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytixinc., Phageluxinc., Nextbiotics, InnoPhage, Ltd, Locus Biosciencesinc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhageProinc., Adaptive Phage Therapeutics, Enbiotixinc., Intodeworldinc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd..
|
|
Key Segments
|
By Type
Escherichia coli
Staphylococcus aureus
Streptococcus
Pseudomonas aeruginosa
Salmonella
and Others
By Applications
Urinary Tract Infections
Chronic Otitis
Dental Extraction
Chronic Ulcerative Colitis
Bone Infection
Wound and Skin Infections
Cystic Fibrosis
and Other
By Route of Administration (Oral
Topical
and Parenteral
|
